Prognostic significance of tumor response as assessed by sequential 18F-fluorodeoxyglucose-positron emission tomography/computed tomography during concurrent chemoradiation therapy for cervical cancer

International Journal of Radiation Oncology Biology Physics

Volumn 87, Issue 3, 2013, Pages 549-554

  Oh, Dongryul ^a   Lee, Jeong Eun ^c   Huh, Seung Jae ^a   Park, Won ^a   Nam, Heerim ^b   Choi, Joon Young ^a   Kim, Byung Tae ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c Kyungpook National University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CONCURRENT CHEMORADIATION; METHODS AND MATERIALS; MULTI VARIATE ANALYSIS; POSITRON EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHIES; PROGNOSTIC SIGNIFICANCE; PROGRESSION FREE SURVIVAL; RECEIVER OPERATING CHARACTERISTIC CURVE ANALYSIS; STANDARDIZED UPTAKE VALUES;

CHEMORADIOTHERAPY; FORECASTING; METABOLISM; POSITRONS; TUMORS;

POSITRON EMISSION TOMOGRAPHY;

CISPLATIN; FLUORODEOXYGLUCOSE F 18; FLUOROURACIL;

ADJUVANT CHEMORADIOTHERAPY; ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DRUG UPTAKE; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HUMAN; IMAGE ANALYSIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; METABOLISM; MULTIPLE CYCLE TREATMENT; PET SCANNER; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RECEIVER OPERATING CHARACTERISTIC; TREATMENT OUTCOME; TREATMENT RESPONSE; UTERINE CERVIX CARCINOMA;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BRACHYTHERAPY; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; CISPLATIN; DISEASE-FREE SURVIVAL; FEMALE; FLUORODEOXYGLUCOSE F18; FLUOROURACIL; HUMANS; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; PROGNOSIS; RADIOPHARMACEUTICALS; RADIOTHERAPY, CONFORMAL; ROC CURVE; SURVIVAL RATE; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 84884870383     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2013.07.009     Document Type: Article

References (23)

1. F.B. Stehman, B.N. Bundy, and P.J. DiSaia Carcinoma of the cervix treated with radiation therapy. I. A multi-variate analysis of prognostic variables in the Gynecologic Oncology Group Cancer 67 1991 2776 2785
2. N.A. Mayr, T. Taoka, and W.T. Yuh Method and timing of tumor volume measurement for outcome prediction in cervical cancer using magnetic resonance imaging Int J Radiat Oncol Biol Phys 52 2002 14 22
3. H. Nam, W. Park, and S.J. Huh The prognostic significance of tumor volume regression during radiotherapy and concurrent chemoradiotherapy for cervical cancer using MRI Gynecol Oncol 107 2007 320 325
4. A.J. Jacobs, C. Faris, and C.A. Perez Short-term persistence of carcinoma of the uterine cervix after radiation. An indicator of long-term prognosis Cancer 57 1986 944 950
5. J.H. Hong, M.S. Chen, and F.J. Lin Prognostic assessment of tumor regression after external irradiation for cervical cancer Int J Radiat Oncol Biol Phys 22 1992 913 917
6. K. Ohara, A. Oki, and Y.O. Tanaka Early determination of uterine cervical squamous cell carcinoma radioresponse identifies high- and low-response tumors Int J Radiat Oncol Biol Phys 64 2006 1179 1182
7. K. Kitajima, K. Murakami, and Y. Kaji Established, emerging and future applications of FDG-PET/CT in the uterine cancer Clin Radiol 66 2011 297 307
8. K. Spaepen, S. Stroobants, and P. Dupont [(18)F]FDG PET monitoring of tumour response to chemotherapy: Does [(18)F]FDG uptake correlate with the viable tumour cell fraction? Eur J Nucl Med Mol Imaging 30 2003 682 688
9. J.K. Schwarz, B.A. Siegel, and F. Dehdashti Association of posttherapy positron emission tomography with tumor response and survival in cervical carcinoma JAMA 298 2007 2289 2295
10. S. Siva, A. Herschtal, and J.M. Thomas Impact of post-therapy positron emission tomography on prognostic stratification and surveillance after chemoradiotherapy for cervical cancer Cancer 117 2011 3981 3988
11. J.K. Schwarz, L.L. Lin, and B.A. Siegel 18-F-fluorodeoxyglucose-positron emission tomography evaluation of early metabolic response during radiation therapy for cervical cancer Int J Radiat Oncol Biol Phys 72 2008 1502 1507
12. M. Bjurberg, E. Kjellen, and T. Ohlsson Prediction of patient outcome with 2-deoxy-2-[18F]fluoro-D-glucose-positron emission tomography early during radiotherapy for locally advanced cervical cancer Int J Gynecol Cancer 19 2009 1600 1605
13. 18F-fluorodeoxyglucose Positron Emisson Tomography/Computed Tomography Guided Conformal Brachytherapy for Cervical Cancer Int J Radiat Oncol Biol Phys 2012
14. G. Ferrandina, G. Macchia, and F. Legge Squamous cell carcinoma antigen in patients with locally advanced cervical carcinoma undergoing preoperative radiochemotherapy: Association with pathological response to treatment and clinical outcome Oncology 74 2008 42 49
15. E. Brun, E. Kjellen, and J. Tennvall FDG PET studies during treatment: Prediction of therapy outcome in head and neck squamous cell carcinoma Head Neck 24 2002 127 135
16. T.S. Aukema, I. Kappers, and R.A. Olmos Is 18F-FDG PET/CT useful for the early prediction of histopathologic response to neoadjuvant erlotinib in patients with non-small cell lung cancer? J Nucl Med 51 2010 1344 1348
17. P. Bystrom, A. Berglund, and U. Garske Early prediction of response to first-line chemotherapy by sequential [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with advanced colorectal cancer Ann Oncol 20 2009 1057 1061
18. V. Safar, J. Dupuis, and E. Itti Interim [18F]fluorodeoxyglucose positron emission tomography scan in diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy plus rituximab J Clin Oncol 30 2012 184 190
19. C.H. Moskowitz, H. Schoder, and J. Teruya-Feldstein Risk-adapted dose-dense immunochemotherapy determined by interim FDG-PET in Advanced-stage diffuse large B-Cell lymphoma J Clin Oncol 28 2010 1896 1903
20. J.K. Schwarz, B.A. Siegel, and F. Dehdashti Metabolic response on post-therapy FDG-PET predicts patterns of failure after radiotherapy for cervical cancer Int J Radiat Oncol Biol Phys 83 2012 185 190
21. E.A. Kidd, M. Thomas, and B.A. Siegel Changes in cervical cancer FDG uptake during chemoradiation and association with response Int J Radiat Oncol Biol Phys 85 2013 116 122
22. M.S. Yoon, S.J. Ahn, and B.S. Nah Metabolic response of lymph nodes immediately after RT is related with survival outcome of patients with pelvic node-positive cervical cancer using consecutive [18F]fluorodeoxyglucose-positron emission tomography/computed tomography Int J Radiat Oncol Biol Phys 84 2012 e491 e497
23. C. Kunos, T. Radivoyevitch, and F.W. Abdul-Karim 18F-fluoro-2-deoxy-D- glucose positron emission tomography standard uptake value ratio as an indicator of cervical cancer chemoradiation therapeutic response Int J Gynecol Cancer 21 2011 1117 1123